Skip to content

Clinic Results of Intraductal Meibomian Gland Probing Combined Intense Pulsed Light in Treating Patients With Refractory Obstructive Meibomian Gland Dysfunction: a randomized controlled trial

Clinic Results of Intraductal Meibomian Gland Probing Combined Intense Pulsed Light in Treating Patients With Refractory Obstructive Meibomian Gland Dysfunction: a randomized controlled trial

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900021273
Enrollment
Unknown
Registered
2019-02-09
Start date
2018-07-01
Completion date
Unknown
Last updated
2019-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Refractory Obstructive Meibomian Gland Dysfunction

Interventions

Group 1:Intraductal Meibomian Gland Probing
Group 2:Intense Pulsed Light
Group 3:intraductal meibomian gland probing (MGP) combined intense pulsed light

Sponsors

The Second Affiliated Hospital, Zhejiang University, School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Aged over 18 years; 2. Fitzpatrick Skin Type 1-4; 3. Standard patient evaluation of eye dryness (SPEED) questionnaire=6; 4. Meibum grade=24 and more than half of the 15 evaluated meibomian gland orifices in each eyelid were obstructed and had no lipid secretion with extrusion; 5. Breakup time of tear film (TBUT) =5s; 6. Schirmer test >5s; 7. Meibo-Scan (OCULUS) showed the atrophy area of meibomian gland in both upper and lower eyelids less than 1/3 of the total area; 8. Did not have symptom relief with conservative treatment (eyelid warming, massage and artificial tears) for at least 1 year before study treatment; 9. Sign informed consent.

Exclusion criteria

Exclusion criteria: Patients with history of corneal contact lens, mite blepharitis, acute eye inflammation or infection and apparent eyelid margin scar as well as patients using lacrimal plug or receiving LASIK were excluded from our study.

Design outcomes

Primary

MeasureTime frame
Standard Patient Evaluation of Eye Dryness score;Tear break-up time (TBUT);Corneal fluorescein staining (CFS);

Secondary

MeasureTime frame
Lid margin finding results;Meibum grade;

Countries

China

Contacts

Public ContactJin Xiuming

Eye Center, Affiliated Second Hospital, School of Medicine, Zhejiang University

lzyjxm@zju.edu.cn+86 571 87783897

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 1, 2026